COMP <GO>
FENC vs UNH // NET PROFIT MARGIN
Fennec Pharmaceuticals Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: FENC 1
— UNH 9
▲ NET PROFIT MARGIN LEADER: UNH
LAST: $10.95 (+0.74%) • MKT CAP: $383.6M
net-margins
-60.00%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FENC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FENC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.57% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -25.90% | 11.47% | -37.37 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.25% | 6.48% | -9.73 | UNH | /fcf-yield <GO> |
| Operating Margin | -14.10% | 4.82% | -18.92 | UNH | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | 3.14% | -63.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -6.10% | 6.46% | -12.56 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.31 | 3.12 | +0.19 | FENC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.0 | 59.2 | -4.20 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $383.6M | $368.83B | -$368.45B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FENC REV | UNH REV | FENC GROSS % | UNH GROSS % | FENC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.6M | $447.57B | — | 88.7% | -$12.5M | $16.07B |
| FY 2024 | $47.5M | $400.28B | — | 88.3% | $27.0M | $20.70B |
| FY 2023 | $21.3M | $371.62B | — | 89.6% | -$17.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FENC // BETA —
UNH // BETA 0.33